与TGF-β信号通路相关的遗传变异调控半月板损伤风险:一项多种族全基因组关联研究
本研究对38,062例半月板损伤患者和700,343例对照进行多种族全基因组关联研究,识别出12个独立的全基因组显著位点,相关基因富集于TGF-β信号通路;多基因风险评分在 European 人群中可区分患者与对照(AUC 0.53),孟德尔随机化显示肥胖遗传易感性增加半月板损伤风险(OR 1.29)。
要点
- 识别出12个与半月板损伤独立相关的全基因组显著位点,相关基因包括UQCC1、BMP6、EGR2、CAPZB、SMG6。
- 相关基因富集于TGF-β信号通路,独立SNP可改变GDF5、BMP6、MMP24、UQCC1等基因表达。
- 多基因风险评分可区分半月板损伤与对照(AUC 0.53),肥胖遗传易感性增加损伤风险(OR 1.29)。
核心结论
- 识别出的12个独立遗传变异提示遗传因素在多种族人群中贡献于半月板损伤风险。
- 这些SNP可能通过改变TGF-β信号通路关键上游调控因子(GDF5、BMP6、TGF-β2)及相关基因(UQCC1、EGR2、MMP24)的表达来调控半月板损伤风险。
- 研究通过孟德尔随机化展示了肥胖与半月板损伤之间的推测因果关系,并提供了经验证的可预测半月板损伤风险的多基因风险评分。
研究设计与样本
- 研究为多种族全基因组关联研究(GWAS),使用NIH All of Us和FinnGen队列的GWAS汇总统计进行Meta分析,纳入38,062例半月板损伤患者和700,343例对照。
- 使用FUMA和MAGMA平台识别兴趣基因,并对全基因组显著SNP进行表达数量性状位点和染色质相互作用映射。
- 使用FinnGen GWAS在European个体中开发多基因风险评分,并在All of Us的European队列中验证。
- 使用孟德尔随机化分析肥胖与半月板损伤之间的推测因果关联。
主要发现
- 识别出12个独立的全基因组显著位点(p < 5 × 10^-8),UQCC1、BMP6、EGR2、CAPZB、SMG6基因在经过对所有已识别基因的Bonferroni校正后(p < 2.6 × 10^-6)与半月板损伤相关。
- 通过MAGMA识别的一部分基因富集于转化生长因子-β(TGF-β)信号通路。
- 独立SNP改变与TGF-β通路相关基因的表达,包括GDF5、BMP6、MMP24和UQCC1。
- 作为UQCC1的独立内含子SNP,rs2425055在间充质干细胞中与GDF5OS存在染色体接触,并降低GDF5OS的表达。
- 半月板损伤的多基因风险评分显示患者与对照之间存在遗传风险差异(曲线下面积0.53 [95%CI 0.51至0.54],每标准差增加的OR 1.10 [95%CI 1.05至1.15];p = 3.34 × 10^-5)。
关键数值与推荐
- 全基因组显著性阈值为p < 5 × 10^-8,对已识别基因进行Bonferroni校正后的阈值为p < 2.6 × 10^-6。
- 多基因风险评分在European个体中区分半月板损伤与对照的曲线下面积为0.53(95%CI 0.51至0.54),每标准差增加的OR为1.10(95%CI 1.05至1.15),p = 3.34 × 10^-5。
- 肥胖遗传易感性与半月板损伤的孟德尔随机化OR为1.29(95%CI 1.24至1.34),p = 9.58 × 10^-38。
临床怎么用
- 作者认为,本GWAS识别的半月板损伤相关基因是半月板再生研究中有前景的治疗靶点。
- 作者认为,经验证的多基因风险评分为开发半月板损伤高风险个体的筛查和预防策略提供了机会。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Numerous clinical risk factors and moderate heritability have been reported for meniscus injury. However, the genetic etiology of meniscus injury remains understudied. This study was a multiancestry genome-wide association study (GWAS) of meniscus injury aimed at identifying genomic variants that influence risk and elucidating the mechanisms by which they may exert their effects. QUESTIONS/PURPOSES: (1) Which single nucleotide polymorphisms (SNPs), genes, and molecular pathways are associated with meniscus injury? (2) How do independent SNPs with genome-wide significance alter the expression of genes within cells related to the meniscus? (3) Can a polygenic risk score (PRS) for meniscus injury discriminate between patients with meniscus injury and controls? (4) Does obesity increase the risk of meniscus injury using a Mendelian randomization framework? METHODS: A meta-analysis of 38,062 patients with meniscus injury and 700,343 control participants was performed using GWAS summary statistics from the NIH's All of Us and FinnGen cohorts. All of Us provided an ancestrally diverse cohort for a multiancestry GWAS. Functional Mapping and Annotation of Genetic Variants (FUMA) and Meta-Analysis Gene-Set Mining of GWAS (MAGMA) platforms were used to identify genes of interest and perform expression quantitative trait loci and chromatin interaction mapping of SNPs with genome-wide significance. A PRS was developed for European individuals using the FinnGen GWAS and was validated on a European cohort from All of Us. Mendelian randomization assesses putative causal associations between an exposure and outcomes given random assortment of alleles during meiotic recombination and was used to analyze the risk of obesity and meniscus injury. RESULTS: Twelve independent genome-wide significant loci (p < 5 × 10 -8 ) were identified, and genes UQCC1 , BMP6 , EGR2 , CAPZB , SMG6 were associated with meniscus injury after Bonferroni correction for all identified genes (p < 2.6 × 10 -6 ). A subset of genes identified through MAGMA were enriched in the transforming growth factor-β (TGF-β) signaling pathway. Independent SNPs altered expression of genes related to the TGF-β pathway, including GDF5 , BMP6 , MMP24 , and UQCC1 . As an independent intronic SNP of UQCC1 , rs2425055 was in chromosomal contact with GDF5OS in mesenchymal stem cells and decreased the expression of GDF5OS . A PRS for meniscus injury demonstrated differences in genetic risk between patients with meniscus injury and control participants (area under the curve 0.53 [95% confidence interval (CI) 0.51 to 0.54], OR per SD increase 1.10 [95% CI 1.05 to 1.15]; p = 3.34 × 10 -5 ). Mendelian randomization demonstrated that genetic predisposition to obesity increased the risk of meniscus injury (OR 1.29 [95% CI 1.24 to 1.34]; p = 9.58 × 10 -38 ). CONCLUSION: The 12 independent genetic variants identified suggest a genetic contribution to meniscus injury risk across multiple ancestries. These SNPs may modulate meniscus injury risk by modifying genetic expression of key upstream regulators of the TGF-β signaling pathway ( GDF5,BMP6,TGF-β2 ) and related genes ( UQCC1,EGR2,MMP24 ). Although previous studies have implicated BMP6 and EGR2 in meniscus fibrochondrocyte differentiation and adaptive stress responses, our results demonstrate that genetic variation related to these genes modifies meniscus injury risk at a population level. In addition to demonstrating a putative causal relationship between obesity and meniscus injury through Mendelian randomization, we present a validated PRS that predicted risk of meniscal injury. CLINICAL RELEVANCE: The genes related to meniscus injury identified in this GWAS are promising therapeutic targets for studies on meniscus regeneration. Our validated PRS presents an opportunity to develop screening and prevention strategies for individuals at high risk of meniscus injury.
引用
- Umesh A, Cordogan S, Simpson SK, et al. Genetic Variants Related to TGF-β Signaling Pathway Modulate Risk of Meniscus Injury: A Multiancestry Genome-wide Association Study. Clin Orthop Relat Res. 2025. PMID: 40971882. doi:10.1097/CORR.0000000000003679
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。